Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-2 90-<97
General Information
Revision date
2022-02-15
Product name
REQUIP TABLETS
Product Synonyms
REQUIP 0.25 MG FILM COATED TABLETS * REQUIP 0.5 MG FILM COATED TABLETS *
supplier name
GlaxoSmithKline Korea
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning!
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Not classified. B. Warning label items including precautionary statement
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Precautionary statements
None. C. Other hazards not included Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. 74.437 % of the mixture consists of component(s) of unknown acute oral toxicity. 88.06 % of the mixture consists of component(s) of unknown acute dermal toxicity. 84.41 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 84.41 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
